Tapewire

Nasdaq · USD

ALNY

ALNYLAM PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3132
SEC CIK
0001178670
Parsed reports
483

Last 12 months

Inside the activity.

0 purchase rows · 279 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025031
Dec 202500
Jan 20260111
Feb 2026011
Mar 20260106
Apr 2026014
May 202600
Jun 202605
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 20, 2016 Filed Dec 22, 2016 21:19 UTC
Vaishnaw AkshayEVP, R&D, CMO
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001325812-16-000107 · edgardoc.xml · derivative · entry 1

Vaishnaw Akshay · CIK 0001458494 · EVP, R&D, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2026-12-20

F1 · shares: Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 25,000 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests.

F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
December 20, 2016 Filed Dec 22, 2016 21:20 UTC
Mason MichaelVP, Finance and Treasurer
GrantStock Option (right to buy) · Derivative 5,550 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001325812-16-000111 · edgardoc.xml · derivative · entry 1

Mason Michael · CIK 0001514291 · VP, Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,550

Underlying: Common Stock · 5,550 shares

Expires 2026-12-20

F1 · shares: Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 5,550 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests.

F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
December 20, 2016 Filed Dec 22, 2016 21:19 UTC
KEATING LAURIESVP, GC & Secretary
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001325812-16-000109 · edgardoc.xml · derivative · entry 1

KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2026-12-20

F1 · shares: Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 25,000 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests.

F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
December 20, 2016 Filed Dec 22, 2016 21:19 UTC
Greenstreet YvonneEVP, Chief Commercial Officer
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001325812-16-000108 · edgardoc.xml · derivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2026-12-20

F1 · shares: Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 25,000 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests.

F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
December 20, 2016 Filed Dec 22, 2016 21:19 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001325812-16-000106 · edgardoc.xml · derivative · entry 1

Greene Barry E · CIK 0001291963 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2026-12-20

F1 · shares: Represents the time-vested portion of the reporting person's 2016 Annual Stock Option award. The reporting person also received an option to purchase 25,000 shares of ALNY common stock that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests.

F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
December 12, 2016 Filed Dec 14, 2016 21:18 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 30,151 $0.00 Strike: $22.75 $0.00
Disclosure

SEC source: 0001325812-16-000097 · primary_doc.xml · derivative · entry 4

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,151 shares

Expires 2016-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents a "net exercise" of outstanding stock options due to expire on December 14, 2016, as permitted under the governing ALNY stock incentive plan. These shares were withheld by ALNY for payment of the option exercise price and applicable tax withholding, based on the closing price of ALNY common stock on December 12, 2016.

F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
December 12, 2016 Filed Dec 14, 2016 21:18 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Tax withholdingCommon Stock 22,710 $42.61 $967,673.10
Disclosure

SEC source: 0001325812-16-000097 · primary_doc.xml · nonDerivative · entry 2

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,370

F1 · kind: Represents a "net exercise" of outstanding stock options due to expire on December 14, 2016, as permitted under the governing ALNY stock incentive plan. These shares were withheld by ALNY for payment of the option exercise price and applicable tax withholding, based on the closing price of ALNY common stock on December 12, 2016.

Read SEC document
December 12, 2016 Filed Dec 14, 2016 21:18 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionCommon Stock 30,151 $22.75 $685,935.25
Disclosure

SEC source: 0001325812-16-000097 · primary_doc.xml · nonDerivative · entry 1

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,080

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents a "net exercise" of outstanding stock options due to expire on December 14, 2016, as permitted under the governing ALNY stock incentive plan. These shares were withheld by ALNY for payment of the option exercise price and applicable tax withholding, based on the closing price of ALNY common stock on December 12, 2016.

Read SEC document
December 01, 2016 Filed Dec 5, 2016 21:55 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 55,605 $0.00 Strike: $22.75 $0.00
Disclosure

SEC source: 0001553878-16-000061 · primary_doc.xml · derivative · entry 6

Greene Barry E · CIK 0001291963 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 55,605 shares

Expires 2016-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2016. The 31,825 options exercised and sold and the 23,780 options exercised and held by the reporting person were due to expire on December 14, 2016.

F6 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

F1 · derivative.expiration_date: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2016. The 31,825 options exercised and sold and the 23,780 options exercised and held by the reporting person were due to expire on December 14, 2016.

Read SEC document
December 01, 2016 Filed Dec 5, 2016 21:55 UTC SaleCommon Stock 500 $44.07 $22,036.00
Disclosure

SEC source: 0001553878-16-000061 · primary_doc.xml · nonDerivative · entry 4

Greene Barry E · CIK 0001291963 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,584

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2016. The 31,825 options exercised and sold and the 23,780 options exercised and held by the reporting person were due to expire on December 14, 2016.

F4 · price: Sale prices ranged from $44.00 to $44.13.

Read SEC document
December 01, 2016 Filed Dec 5, 2016 21:55 UTC SaleCommon Stock 16,976 $43.28 $734,746.74
Disclosure

SEC source: 0001553878-16-000061 · primary_doc.xml · nonDerivative · entry 3

Greene Barry E · CIK 0001291963 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,084

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2016. The 31,825 options exercised and sold and the 23,780 options exercised and held by the reporting person were due to expire on December 14, 2016.

F3 · price: Sale prices ranged from $43.00 to $43.92.

Read SEC document
December 01, 2016 Filed Dec 5, 2016 21:55 UTC SaleCommon Stock 14,349 $42.61 $611,344.88
Disclosure

SEC source: 0001553878-16-000061 · primary_doc.xml · nonDerivative · entry 2

Greene Barry E · CIK 0001291963 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,060

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2016. The 31,825 options exercised and sold and the 23,780 options exercised and held by the reporting person were due to expire on December 14, 2016.

F2 · price: Sale prices ranged from $42.00 to $42.99.

Read SEC document
December 01, 2016 Filed Dec 5, 2016 21:55 UTC Exercise / conversionCommon Stock 55,605 $22.75 $1,265,013.75
Disclosure

SEC source: 0001553878-16-000061 · primary_doc.xml · nonDerivative · entry 1

Greene Barry E · CIK 0001291963 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,409

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2016. The 31,825 options exercised and sold and the 23,780 options exercised and held by the reporting person were due to expire on December 14, 2016.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 21:59 UTC
Vaishnaw AkshayEVP, R&D, CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 29,165 $0.00 Strike: $22.75 $0.00
Disclosure

SEC source: 0001553878-16-000060 · primary_doc.xml · derivative · entry 6

Vaishnaw Akshay · CIK 0001458494 · EVP, R&D, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,165 shares

Expires 2016-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2016. The 29,165 options exercised and sold by the reporting person were due to expire on December 14, 2016.

F6 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

F1 · derivative.expiration_date: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2016. The 29,165 options exercised and sold by the reporting person were due to expire on December 14, 2016.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 21:59 UTC
Vaishnaw AkshayEVP, R&D, CMO
SaleCommon Stock 1,500 $46.14 $69,208.05
Disclosure

SEC source: 0001553878-16-000060 · primary_doc.xml · nonDerivative · entry 4

Vaishnaw Akshay · CIK 0001458494 · EVP, R&D, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,750

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2016. The 29,165 options exercised and sold by the reporting person were due to expire on December 14, 2016.

F4 · price: Sale prices ranged from $45.98 to $46.80.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 21:59 UTC
Vaishnaw AkshayEVP, R&D, CMO
SaleCommon Stock 13,297 $45.55 $605,662.39
Disclosure

SEC source: 0001553878-16-000060 · primary_doc.xml · nonDerivative · entry 3

Vaishnaw Akshay · CIK 0001458494 · EVP, R&D, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,250

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2016. The 29,165 options exercised and sold by the reporting person were due to expire on December 14, 2016.

F3 · price: Sale prices ranged from $44.98 to $45.95.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 21:59 UTC
Vaishnaw AkshayEVP, R&D, CMO
SaleCommon Stock 14,368 $44.34 $637,127.41
Disclosure

SEC source: 0001553878-16-000060 · primary_doc.xml · nonDerivative · entry 2

Vaishnaw Akshay · CIK 0001458494 · EVP, R&D, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,547

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2016. The 29,165 options exercised and sold by the reporting person were due to expire on December 14, 2016.

F2 · price: Sale prices ranged from $43.90 to $44.86.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 21:59 UTC
Vaishnaw AkshayEVP, R&D, CMO
Exercise / conversionCommon Stock 29,165 $22.75 $663,503.75
Disclosure

SEC source: 0001553878-16-000060 · primary_doc.xml · nonDerivative · entry 1

Vaishnaw Akshay · CIK 0001458494 · EVP, R&D, CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2016. The 29,165 options exercised and sold by the reporting person were due to expire on December 14, 2016.

Read SEC document
October 13, 2016 Filed Oct 14, 2016 20:22 UTC PurchaseCommon Stock 27,900 $37.00 $1,032,327.90
Disclosure

SEC source: 0001553878-16-000059 · edgardoc.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 27,900

F1 · ownership.nature: The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.

Read SEC document
October 12, 2016 Filed Oct 14, 2016 20:17 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 4,019 $0.00 Strike: $18.66 $0.00
Disclosure

SEC source: 0001553878-16-000057 · primary_doc.xml · derivative · entry 5

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,981

Underlying: Common Stock · 4,019 shares

Expires 2022-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
October 12, 2016 Filed Oct 14, 2016 20:17 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,521 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0001553878-16-000057 · primary_doc.xml · derivative · entry 4

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,915

Underlying: Common Stock · 3,521 shares

Expires 2021-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
October 12, 2016 Filed Oct 14, 2016 20:17 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,019 $18.66 $74,994.54
Disclosure

SEC source: 0001553878-16-000057 · primary_doc.xml · nonDerivative · entry 2

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,929

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 12, 2016 Filed Oct 14, 2016 20:17 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,521 $7.10 $24,999.10
Disclosure

SEC source: 0001553878-16-000057 · primary_doc.xml · nonDerivative · entry 1

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,910

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2016 Filed Sep 21, 2016 22:33 UTC
Greenstreet YvonneEVP, Chief Operating Officer
GrantStock Option (right to buy) · Derivative 125,000 $0.00 Strike: $77.10 $0.00
Disclosure

SEC source: 0001553878-16-000056 · edgardoc.xml · derivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2026-09-18

F1 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.